MYOCARDITIS TOXOPLASMAL

MYOCARDITIS TOXOPLASMAL was reported 17 times

MYOCARDITIS TOXOPLASMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 2 0.0007
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0003
2 Antimalarial [EPC] 2 0.0002
3 Antiprotozoal [EPC] 2 0.0002
4 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
5 Nucleoside Analog Antiviral [EPC] 5 0.0001
6 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
7 Antimetabolite Immunosuppressant [EPC] 1 0.0000
8 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 3 0.0000
9 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
10 Azole Antifungal [EPC] 4 0.0000
11 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3 0.0000
12 Polyene Antifungal [EPC] 1 0.0000
13 Amide Local Anesthetic [EPC] 2 0.0000
14 Antiarrhythmic [EPC] 2 0.0000
15 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
16 Alkylating Drug [EPC] 4 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
18 Glycopeptide Antibacterial [EPC] 1 0.0000
19 Nitroimidazole Antimicrobial [EPC] 1 0.0000
20 Tetracycline-class Drug [EPC] 1 0.0000
21 Topoisomerase Inhibitor [EPC] 1 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
25 Kinase Inhibitor [EPC] 4 0.0000
26 Leukocyte Growth Factor [EPC] 1 0.0000
27 Osmotic Laxative [EPC] 2 0.0000
28 Janus Kinase Inhibitor [EPC] 1 0.0000
29 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
30 Insulin Analog [EPC] 2 0.0000
31 Loop Diuretic [EPC] 2 0.0000
32 Corticosteroid [EPC] 5 0.0000
33 Proton Pump Inhibitor [EPC] 2 0.0000
34 Platelet Aggregation Inhibitor [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000